Sharlene Gill, President of the Canadian Association of Medical Oncologists, recently shared the following insight on X/Twitter:
“NETTER-2
Lutathera in adv SSTR+ hi G2 and G3 GEP-NETs (Ki67 10-55%) by Dr. Simron Singh:
– PFS HR 0.27 (p<0.0001),
– ORR 43%*
This is practice changing.”
Source: Sharlene Gill/X
